The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3,5-di(benzylidene)-1-(4-(3-(4-chlorophenyl)-3-oxoprop-1-en-1-yl)benzoyl)piperidin-4-one ID: ALA5287486
Max Phase: Preclinical
Molecular Formula: C35H26ClNO3
Molecular Weight: 544.05
Associated Items:
Names and Identifiers Canonical SMILES: O=C1/C(=C/c2ccccc2)CN(C(=O)c2ccc(/C=C/C(=O)c3ccc(Cl)cc3)cc2)C/C1=C\c1ccccc1
Standard InChI: InChI=1S/C35H26ClNO3/c36-32-18-16-28(17-19-32)33(38)20-13-25-11-14-29(15-12-25)35(40)37-23-30(21-26-7-3-1-4-8-26)34(39)31(24-37)22-27-9-5-2-6-10-27/h1-22H,23-24H2/b20-13+,30-21+,31-22+
Standard InChI Key: FPEMUEDCPCBZJD-ROOOYFERSA-N
Molfile:
RDKit 2D
40 44 0 0 0 0 0 0 0 0999 V2000
-5.3463 0.8254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6315 0.4136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9199 0.8234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9199 1.6468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6361 2.0603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3463 1.6447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2071 2.0584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4939 1.6467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7808 2.0584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7808 2.8818 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0678 1.6467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3547 2.0584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3583 1.6467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0715 2.0582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7822 1.6471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7822 0.8234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0734 0.4124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3583 0.8197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0678 0.8233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7808 0.4116 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4939 0.8233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7808 -0.4117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0678 -0.8234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3545 -0.4119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3560 -0.8230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3560 -1.6467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3527 -2.0577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0678 -1.6504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0690 -2.0584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7822 -1.6467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4953 -2.0584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2083 -1.6467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2086 -0.8232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9199 -0.4134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6332 -0.8252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6348 -1.6446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9245 -2.0602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4953 -2.8818 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.4939 -0.8234 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3463 -0.4136 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 2 0
9 8 1 0
9 10 2 0
11 9 1 0
11 12 2 0
12 13 1 0
14 13 2 0
15 14 1 0
16 15 2 0
17 16 1 0
18 17 2 0
13 18 1 0
19 11 1 0
20 19 1 0
21 20 1 0
8 21 1 0
20 22 1 0
22 23 1 0
24 23 2 0
25 24 1 0
26 25 2 0
27 26 1 0
28 27 2 0
23 28 1 0
26 29 1 0
29 30 2 0
30 31 1 0
31 32 1 0
33 32 2 0
34 33 1 0
35 34 2 0
36 35 1 0
37 36 2 0
32 37 1 0
31 38 2 0
22 39 2 0
35 40 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 544.05Molecular Weight (Monoisotopic): 543.1601AlogP: 7.43#Rotatable Bonds: 6Polar Surface Area: 54.45Molecular Species: NEUTRALHBA: 3HBD: ┄#RO5 Violations: 2HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 7.88CX LogD: 7.88Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.19Np Likeness Score: -0.46
References 1. Moreira J, Saraiva L, Pinto MM, Cidade H.. (2020) Diarylpentanoids with antitumor activity: A critical review of structure-activity relationship studies., 192 [PMID:32172081 ] [10.1016/j.ejmech.2020.112177 ]